Loading
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Jan 2018 for REPROS THERAPEUTICS INC., €45k.
Insider track record
Disclosed buys
7
Disclosed sells
0
Signal history
Closed purchases
Market purchases
7
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Katherine Anderson: trading record in brief
Katherine Anderson discloses dealings in Repros Therapeutics Inc. to SEC (Form 4). The record holds 14 filings, for trades running from 13 April 2012 to 29 January 2018.
No open-market sale appears; the market trades are 7 purchases worth €107k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants.
In size, the median ticket on the buying side is €13k.
On 31 January 2018 came the latest disclosure, a transaction for €45k in Repros Therapeutics Inc. The last purchase on record was published on 28 January 2016, which is 3,922 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Katherine Anderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
83,875 shares@ US$0.6779.1% of flowCommon StockSEC:0001144204-18-004777:0
10,000 sharesCommon StockSEC:0001144204-17-035636:0
10,000 sharesCommon StockSEC:0001144204-17-030841:0
10,000 sharesCommon StockSEC:0001144204-17-023631:0
10,000 sharesCommon StockSEC:0001144204-17-018857:0
10,000 sharesCommon StockSEC:0001144204-17-012515:0
10,000 sharesCommon StockSEC:0001144204-17-005935:0
12,000 shares@ US$1.08100.0% of flowCommon StockSEC:0001144204-16-077572:0
Canonical exit: 26 Apr 2016 (T+90)
3,500 shares@ US$9.41Common StockSEC:0001144204-14-067297:0
Canonical exit: 10 Feb 2015 (T+90)
2,000 shares@ US$13.85Common StockSEC:0001144204-14-050109:0
Canonical exit: 12 Nov 2014 (T+90)
1,000 shares@ US$17.90Common StockSEC:0001476301-13-000002:0
Canonical exit: 23 Jan 2014 (T+90)
1,000 shares@ US$23.77Common StockSEC:0000897075-13-000001:0
Canonical exit: 8 Jan 2014 (T+90)
1,000 shares@ US$11.89Common StockSEC:0001476301-13-000001:0
Canonical exit: 2 May 2013 (T+90)
3,000 shares@ US$3.86Common StockSEC:0001181431-12-024045:0
Canonical exit: 12 Jul 2012 (T+90)
14 of 14 declarations
